Satisfaction with prophylactic risk-reducing salpingo-oophorectomy in BRCA mutation carriers is very high and little dependent on the participants’ characteristics at surgery: a prospective study-Reference-Cited by-同舟云学术

Satisfaction with prophylactic risk-reducing salpingo-oophorectomy in BRCA mutation carriers is very high and little dependent on the participants’ characteristics at surgery: a prospective study

Published:2021-02-01 Issue:3 Volume:28 Page:263-270
ISSN:1530-0374
Container-title:Menopause
language:en
Short-container-title:

Author:

Grandi Giovanni,Sammarini Margaret,Cortesi Laura,Toss Angela,Botticelli Laura,Varliero Federico,Sighinolfi Giovanna,Barbieri Elena,Facchinetti Fabio

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Earth and Planetary Sciences,General Environmental Science,Obstetrics and Gynecology

Reference29 articles.

1. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers;Kuchenbaecker;JAMA,2017

2. Hereditary ovarian cancers: state of the art;Toss;Minerva Med,2019

3. Evaluation of transvaginal ultrasound plus CA-125 measurement and prophylactic salpingo-oophorectomy in women at different risk levels of ovarian cancer: the Modena Study Group Cohort Study;Cortesi;Oncology,2017

4. The reduction of CA 125 serum levels in BRCA 1/2 mutation carriers after risk-reducing salpingo-oophorectomy is only partially associated with surgery: a prospective cohort, other biomarker controlled, study;Grandi;Eur J Cancer Prev,2020

5. Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers;Rebbeck;Eur J Cancer,2002

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sexual Function in Women Diagnosed with Hereditary Breast and Ovarian Cancer Syndrome;Cancers;2024-07-21

2. Risk-Reducing Salpingo-Oophorectomy (RRSO) Combined with Simultaneous Mastectomy in Women with BRCA 1–2 Mutation Carriers: The Surgical Technique, the Feasibility and Patients’ Satisfaction of Multiple Surgeries;Journal of Clinical Medicine;2022-12-18

3. BRCA mutation carriers’ perceptions on postmenopausal hormone therapy: An Italian study;Psycho-Oncology;2021-05-28